Results 141 to 150 of about 8,016,307 (335)

Minimal resolving sets for the hypercube

open access: yes, 2011
For a given undirected graph $G$, an \emph{ordered} subset $S = {s_1,s_2,...,s_k} \subseteq V$ of vertices is a resolving set for the graph if the vertices of the graph are distinguishable by their vector of distances to the vertices in $S$. While a superset of any resolving set is always a resolving set, a proper subset of a resolving set is not ...
openaire   +2 more sources

The Analysis of Airport Passengers Flow by Using Spatial Temporal Graph Neural Networks and Resolving Efficient Dominating Set [PDF]

open access: hybrid, 2023
Ahmad Muklisin   +4 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

On minimal doubly resolving sets in graphs

open access: yes, 2021
Two vertices u,v of connected graph G are doubly resolved by x,y\in V(G)if d(v; x)-d(u; x)\neq d(v; y)-d(u; y): A set W of vertices of the graph G is a doubly resolving set for G if every two distinct vertices of G are doubly resolved by some two vertices of W. (G) is the minimum cardinality of a doubly resolving set for the graph G.
openaire   +2 more sources

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Resolving species boundaries in a recent radiation with the Angiosperms353 probe set: the Lomatium packardiae/L. anomalum clade of the L. triternatum (Apiaceae) complex

open access: green, 2021
Micheal V. Ottenlips   +8 more
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

A conceptual framework for the dynamic modeling of time-resolved phenotypes for sets of genotype-environment-management combinations: a model library [PDF]

open access: gold, 2023
George A.K. van Voorn   +8 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy